Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms
Atorvastatin reduces tissue factor expression in adipose tissue of atherosclerotic rabbits
Atorvastatin downregulates BMP-2 expression induced by oxidized low-density lipoprotein in human umbilical vein endothelial cells
Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages
Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: Impact on plasma adiponectin level
Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1
Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan
Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3 beta signaling pathways
Atorvastatin Inhibits Myocardin Expression in Vascular Smooth Muscle Cells
Atorvastatin May Delay Cardiac Aging by Upregulating Peroxisome Proliferator-Activated Receptors in Rats
Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles
Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway
Atorvastatin inhibits collar-induced intimal thickening of rat carotid artery: Effect on C-type natriuretic peptide expression
Atorvastatin and whisker stimulation synergistically enhance angiogenesis in the barrel cortex of rats following focal ischemia
Atorvastatin modulates the DDAH1/ADMA system in high-fat diet-induced insulin-resistant rats with endothelial dysfunction
Atorvastatin Inhibits Homocysteine-Induced Endoplasmic Reticulum Stress through Activation of AMP-Activated Protein Kinase
Atorvastatin attenuates the production of IL-1 beta, IL-6, and TNF-alpha in the hippocampus of an amyloid beta 1-42-induced rat model of Alzheimer's disease
Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease
Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression
Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio
Atorvastatin Inhibits the 5-Lipoxygenase Pathway and Expression of CCL3 to Alleviate Atherosclerotic Lesions in Atherosclerotic ApoE Knockout Mice
Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-Kras(G12D)-LSL-Trp53(R172H)-Pdx1-Cre mice
Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia
Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells
Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1 alpha/CXCR-4 Axis
Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway
Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction
Atorvastatin Suppresses Aldosterone-induced Neonatal Rat Cardiac Fibroblast Proliferation by Inhibiting ERK1/2 in the Genomic Pathway
Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis (vol 18, pg 303, 2010)
Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines
Atorvastatin prevents amyloid-beta peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway
Atorvastatin suppresses Toll-like receptor 4 expression and NF-kappa B activation in rabbit atherosclerotic plaques
Atorvastatin preconditioning improves the forward blood flow in the no-reflow rats
Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects
Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-a-induced protein 8-like 2 in RAW264.7 cells
Atorvastatin inhibits hyperglycemia-induced expression of osteopontin in the diabetic rat kidney via the p38 MAPK pathway
Atorvastatin Combining with Probucol: A New Way to Reduce Serum Uric Acid Level during Perioperative Period of Interventional Procedure
Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-kappa B activation in hypoxic pulmonary hypertensive rats
Atorvastatin ameliorates contrast medium-induced renal tubular cell apoptosis in diabetic rats via suppression of Rho-kinase pathway
Atorvastatin Protects Vascular Smooth Muscle Cells From TGF-beta 1-Stimulated Calcification by Inducing Autophagy via Suppression of the beta-Catenin Pathway
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
Atorvastatin Represses the Angiotensin 2-Induced Oxidative Stress and Inflammatory Response in Dendritic Cells via the PI3K/Akt/Nrf 2 Pathway
Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
Atorvastatin Improves Survival of Implanted Stem Cells in a Rat Model of Renal Ischemia-Reperfusion Injury
Atorvastatin increases endothelial progenitor cells in balloon-injured mouse carotid artery
Atorvastatin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in rats
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density Lipoprotein
Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery Aneurysms
Atorvastatin-Loaded Hydrogel Affects the Smooth Muscle Cells of Human Veins
Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: Pleiotropic evidence from plasma mRNA analyses
Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in a rat endometriosis model
Atorvastatin for ovarian torsion: effects on follicle counts, AMH, and VEGF expression
Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects >= 65 years
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis
Atorvastatin, Etidronate, or Both in Patients at High Risk for Atherosclerotic Aortic Plaques: A Randomized, Controlled Trial
Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex
Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver
Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells
Atorvastatin in combination with ezetimibe and carotid atherosclerosis
Atorvastatin Reduces the Proadhesive and Prothrombotic Endothelial Cell Phenotype Induced by Cocaine and Plasma From Cocaine Consumers In Vitro
Atorvastatin administration is associated with dose-related changes in IGF bioavailability
Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley rats
Atorvastatin prevents cell damage via modulation of oxidative stress, glutamate uptake and glutamine synthetase activity in hippocampal slices subjected to oxygen/glucose deprivation
Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease
Atorvastatin favorably modulates proinflammatory cytokine profile in patients following deep vein thrombosis
Atorvastatin inhibits CXCR7 induction to reduce macrophage migration
Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia
Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats
Atorvastatin Attenuates TNF-alpha Production via Heme Oxygenase-1 Pathway in LPS-stimulated RAW264.7 Macrophages
Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice
Atorvastatin attenuates the paraquat-induced pulmonary inflammation via PPAR gamma receptors: A new indication for atorvastatin
Atorvastatin Treatment Improves Myocardial and Peripheral Blood Flow in Familial Hypercholesterolemia Subjects without Evidence of Coronary Atherosclerosis
Atorvastatin Therapy Is Not Associated with Slowing the Progression of Aortic Stenosis: Findings of a Randomized Controlled Trial
Atorvastatin-Loaded Oleic Acid Nanoglobules for Oral Administration: In Vitro Characterization and Biopharmaceutical Evaluation
Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial
Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women
Atorvastatin prevents type 2 diabetes mellitus-An experimental study
Atorvastatin is beneficial for muscle reinnervation after complete sciatic nerve section in rats
Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133(+)CD44(+) prostate cancer stem cells